Microfluidic-Mass Spectrometry Analysis of Blood-Brain Barrier Transport Using Engineered Microparticle Interfaces

Key Points

• The research aims to analyze blood-brain barrier transport mechanisms using engineered microparticle interfaces.
• Utilized microfluidic technology for in vitro models of the blood-brain barrier.
• Employed mass spectrometry for analyzing substance transport.
• Engineered microparticles to study interactions with the barrier.
• Demonstrated improved transport efficiency across the blood-brain barrier.
• Identified specific mechanisms that facilitate drug delivery.
• Provided data supporting the use of engineered interfaces for drug testing.